Russia Eyes Producing COVID-19 Vaccine in India

With its COVID-19 vaccine "Sputnik V" in phase 3 of clinical trials, Russia seeks to establish a partnership with India for the production of the vaccine. CEO of Russian Direct Investment Fund (RDIF) Kirill Dmitriev on August 20 told India has the manufacturing capability to mass produce the vaccine. The vaccine was developed by the Gamaleya Research Institute of Epidemiology and Microbiology, with support of RDIF.